0.2282
+0.0048
+(2.15%)
At close: January 31 at 7:35:21 PM GMT+1
Key Executives
Key Executives Information Not Available
Nykode Therapeutics AS
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Nykode Therapeutics AS’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 26, 2025 at 10:59 AM UTC
Nykode Therapeutics AS Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
NP5.DE Newron Pharmaceuticals S.p.A.
10.18
+3.14%
ONCO.CN Onco-Innova
2.0400
+6.81%
ALNY Alnylam Pharmaceuticals, Inc.
271.31
-2.11%
VRNA Verona Pharma plc
57.30
+0.10%
NRXP NRx Pharmaceuticals, Inc.
3.0200
+1.00%
TVGN Tevogen Bio Holdings Inc.
1.4900
+11.19%
MNMD Mind Medicine (MindMed) Inc.
6.79
-4.77%
TGTX TG Therapeutics, Inc.
31.70
-4.98%
XFOR X4 Pharmaceuticals, Inc.
0.7001
+5.74%
SLS SELLAS Life Sciences Group, Inc.
1.6200
+21.80%